It was fantastic to see everyone that has put so much into Neuro-Bio all under the same roof and we would like to say a massive thank you to all who came. There were some very interesting and inspirational speeches given by Neuro-Bio’s Chairman, Lord James Arbuthnot, Peter Yates AM, Jim Demetriades and Baroness Professor Susan Greenfield, CEO and Founder of Neuro-Bio. We hope you all enjoyed it as much as we did.
Neuro-Bio has recently received a kind gift of £780 from Josie Duffy who is a social worker and who received support from colleagues, friends and family.
Josie has been busy raising money from raffles, tombola and lunches. This is to support the company’s research efforts into a new therapy for Alzheimer’s disease. The gift will be put towards on-going work by the Neuro-Bio team looking to develop a new blood test for detecting Alzheimer’s disease in patients several years before the normal signs of memory loss become obvious. If patients can be detected earlier, then new treatment options, such as those also being developed by Neuro-Bio, can be given to the patients. Neuro-Bio’s CEO, Baroness Susan Greenfield, commented “From the whole team we would like to say a huge thank you to Josie for her support. We are delighted to receive this kind donation and extremely grateful to Josie for all her fundraising efforts that will go towards finding a new therapy for Alzheimer’s. This act of simple human kindness makes our work worthwhile and motivates us even more to find a new therapy for this debilitating disease.”
Click here for the full release: RMH PR
Baroness Susan Greenfield will be cutting the ribbon to open HEADWAY, Oxfordshire’s brand new Activity & Rehabilitation Centre. More Information –>
Headway Oxfordshire 5 May 17 Invite
HEADWAY Oxfordshire support people affected by acquired brain injury across Oxfordshire.
Susan Greenfield’s latest interview in The Australian – Click here to read full article
We are pleased to announce that the European Patent Office intends to grant our application for a patent – Neurodegenerative Disorders
Neuro-Bio Ltd Application No. 14736948.2
Click here to read the full Press Release –> Neuro-Bio press release for release 17th March
Friday 19 May 2017 at 10:00 – World Precision Medicine Congress 2017, Business Design Centre, 52 Upper Street, Islington, London N1 0QH – Precision medicine and neurodegenerative disease
Tuesday 6 June/Wednesday 7 June 2017 – OECD Forum Paris, France – Details still to be finalised
Congratulations to Sara Garcia-Rates on her return from maternity leave and to Emily Smith whoa gave birth to Amelia in December
For the full article, please click here.
Neuro-Bio Ltd. has identified a peptide derived from AChE — the enzyme responsible for breaking down acetylcholine — and believes the fragment is the main pathological driver in Alzheimer’s disease, acting upstream of β-amyloid and tau in the brain centers hit earliest in the disease.